Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.
New film on Zoonoses RIVM aims to improve the collaboration between the human and veterinary health sectors. This makes it possible to intervene quickly and efficiently in case of a zoonotic disease outbreak.
Increasing number of girls immunised against HPV In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.
Aquatic organisms inadequately protected against insecticide imidacloprid RIVM proposes that the water quality standard for the insecticide imidacloprid be reduced by a factor of eight.
RIVM investigates dangers of e-cigarette At the request of State Secretary Martin van Rijn (VWS), RIVM is carrying out an investigation into the safety of e-cigarettes.
Annual GLOBE day: A closer look at RIVM soil Today, April 8th, RIVM welcomes education professionals for the annual GLOBE day.
Small bite, big threat Today is World Health Day, which focuses on diseases that are passed on by creatures such as mosquitoes and ticks. These include malaria, dengue fever and Lyme disease.
RIVM in Brazil: deployment of a subsoil water system for a climate proof and healthy city This week, a delegation of RIVM gave a training course in Brazil about policy relevant to soil.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.